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FATE OF STREPTOCOCCAL M PROTEIN AFTER EXPOSURE TO
PLASMIN AND HUMAN LEUKOCYTES**
Untreated group A streptococcal infections are followed by a durable type-
specific immunity. Antibodies responsible for this immunity are directed
against the M antigen and although late in appearance, have been reported
to persist for 30 years.' Attempts to induce type-specific immunity in
humans by means of bacterial vaccines and partially purified preparations of
M protein' have met with limited success. The contrast of long lasting
natural immunity with the weak response to purified antigens led to these
studies on the disposition of M protein in host tissues and fluids.
In the present work M protein has been exposed to streptokinase-
activated plasminogen, and to viable human leukocytes. Following such
exposure the fate of M antigen, in purified form and intact on the bacterial
cell wall, has been explored by precipitin and immunofluorescent techniques.
MATERIALS AND METHODS
One lyophilized strain of type 12 (SF42)t and two strains of type 1 streptococci were
used. Strain T1/162/7 was obtained in the lyophilized statet: and strain T1/2788 as
phenolized bacterial cells.¶f After repeated serial mouse passage the LD50 of both
T1/162/7 and SF42 for 30 gram white mice reached 10-50 organisms: daily sub-
cultures from human blood agar plates were then employed and new cultures were
taken from lyophilized stock whenever loss of virulence was shown by an inability to
grow in normal human blood.8
Heterologous type strains were similarly maintained and were used in absorbing
and testing specificity of antisera: they were 165/2 (type 3), 169/2 (type 6), and C203
(type 3).
Media: All streptococcal cultures were grown in Todd-Hewitt (Difco) media.
Subcultures were plated on 5 per cent human blood agar.
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Preparation of M protein: Partially purified M protein was prepared from T1/2788
streptococcal cells by the method of Lancefield and Perlmann.' Boundary electro-
phoresis of this material at pH 8.6 revealed migration as a single peak but with
sufficient boundary spreading to suggest some heterogeneity. No further purification
was attempted.
Enzymes: Plasminogen (profibrinolysin) was prepared from Cohn's plasma Fraction
III, by the method of Kline.' Starting with 10 gm. of Fraction III the final enzyme
solution was concentrated by lyophilization and dissolved in 4 ml. of distilled water
to which two drops of N HC1 were added. Streptokinase was obtained as Varidase®
(Lederle lot 2200-630A), a commercially available preparation also containing desoxy-
ribonuclease. Dilutions were prepared in 0.01 M phosphate buffer at pH 7.6. In
preliminary experiments casein was used as substrate; proteolysis was determined by an
increase in optical density at 280 m,u of the filtrate following trichloracetic acid precipi-
tation. The use of skimmed milk was adopted as a substrate to monitor proteolytic
activity following the methods of Kramer' and Barnett.' The advantage of this system
is that proteolysis of suspended casein leads to clearing of opalescent skimmed milk,
an easily perceived end-point. Skimmed milk (Pet®) was obtained in the dried
form, prepared as a 20 per cent solution, autoclaved for 10 minutes at 15 lb. pressure
and tested for sterility.
Leukocytes: The same human donor was used for all leukocyte experiments. Blood
was aseptically withdrawn from the antecubital vein into a syringe containing heparin
(Liquaemin,g Organon, Inc.), in final concentration of 0.1 mg/ml. The syringe was
placed vertically in the refrigerator and blood allowed to sediment for 1-2 hours;
thereupon the plasma and buffy coat were removed and the leukocytes washed, at 4°C.,
three times in Tyrode's buffer containing .1 per cent gelatin (Knox). Leukocytes
were counted in a Neubauer counting chamber using 1 per cent acetic acid as diluent.
No attempt was made to further separate red cells from the leukocyte preparation.
Leukocyte "buttons" were prepared by a modification of a method originally
described by Wright.5 A drop of fingertip blood was allowed to clot on a clean glass
slide in a moist Petri dish at 370 for 30 minutes. The clot was then covered with
Gey's buffer solution containing 1 per cent human serum albumin and removed
with a fine forceps. Leukocytes persisted as a disc, affixed to the surface of the slide,
even after vigorous washing in Gey's albumin buffer. These leukocytes, largely
polymorphonuclear, remained viable and phagocytic.
Antisera: Group and type-specific antistreptococcal sera were made available
through the courtesy of Dr. John Winn, Diagnostic Reagent Section, Communicable
Disease Center, in Chamblee, Georgia. Precipitin tests were performed with the
capillary tube technique.9
Immunofluorescent methods: Fluorescein conjugates were prepared from antisera
obtained by immunizing rabbits with repeated injections of whole heat-killed organisms
for a five week course. Strain No. SF42 was used to prepare type 12 antisera, and
strain No. T1/162/7 for type 1 antisera. Two weeks after the last injection rabbit
sera were tested for the presence of type-specific antibody by direct and indirect
bactericidal tests.8 These were confirmed by production of long chains of homologous
streptococci grown in the antiserum.'0 Gamma globulin prepared from antisera was
conjugated with fluorescein isothiocyanate by the method of Riggs, et al.' After
exhaustive dialysis the conjugate was purified on DEAE cellulose (Eastman) column.
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Ion exchange material was first cycled three times with N HCl alternating with
N NaOH. It was then washed with 0.005 M phosphate buffer at pH 8.3 in a 4-liter
beaker and allowed to sediment for one hour. The supernate, which contained small
fibers, was decanted and the washing repeated three times. The suspension of ion
exchange material was then poured into a 20 mm. column and allowed to pack by
gravity. Approximately one liter of 0.005 M buffer was run through the column by
gravity alone. The effluent was then checked to confirm the pH of 8.3. Fluorescein
conjugated gamma globulin was dialyzed against starting buffer and run into the
column at six drops per minute. After loading with approximately 100 mg. of
protein, 0.005 M buffer was again run through the column at the same rate. Little
or none of the fluorescein conjugate appeared in the initial effluent. With change of
buffer to 0.06 M phosphate at pH 6.3, a band of fluorescent material could be followed
with a Wood's lamp as it traveled down the column. The effluent was collected in
150 ml. of buffer. After concentration to 20 ml. by flash evaporation, the conjugate
was dialyzed against 0.01 M phosphate buffered saline at pH 7.2. It was then absorbed
twice with equal volumes of packed bacterial cells of strain No. T6/169/7 (type 6)
and C203 (type 3). Each absorption proceeded at 370 for two hours with mild
agitation and was completed by overnight incubation at 40 C. To remove non-
specific staining properties for human leukocytes, the conjugate was finally absorbed
with Y2 volume of packed human spleen homogenate prepared as follows: freshly
obtained human spleen tissue weighing 20 gm. was minced in 40 ml. of saline and
homogenized in a Waring blendor at 40 C. until a fine suspension was made. The
resulting homogenate was frozen and thawed to effect lysis of the red cells, and
washed five times with buffered saline to remove hemoglobin from the suspension.
The washed homogenate was then centrifuged in conical tubes at 2,500 rpm for
30 minutes and the fluorescein conjugate added to packed tissue homogenate. Finally,
the purified, absorbed conjugate was dispensed in 2 ml. screw-capped vials and frozen
at -20°C. until used. No preservatives were added.
Fixation and staining: Smears of bacterial suspensions were heat fixed. Slides
containing leukocyte discs were fixed by rapid drying in an air jet. To a dry
slide, one drop of specific conjugate was added, and reaction allowed to occur for
50 minutes in a moist chamber. The slides were then washed in two changes of
buffered saline, pH 7.2, for 10 minutes, with gentle agitation on a shaking machine.
Wet mounts were prepared with glycerol buffer.
Specificity of staining: The following criteria were met to control specificity of
staining: 1) conjugates were completely absorbed with homologous partially purified
M protein; 2) fluorescent staining was inhibited by prior treatment of slides with
unlabelled specific antisera; 3) heterologous conjugates failed to stain test organisms;
4) pepsin-treated bacterial cells did not stain.
For the last control bacterial cells were suspended in a 2 per cent solution of
pepsin (Difco, 1:10,000) and the reaction lowered to pH 2. After incubation
for two hours at 370 C. the suspension was neutralized and the cells washed twice
in the cold. Controlled suspensions without pepsin were always included.
Microscopy and photography: The Leitz microscope was equipped with an Osram
HBO 200 ultraviolet light source, a UGI 2 mm. exciter filter, and the D1.20 dark
field condenser; a T-tube arrangement allowed alternate illumination of the same
microscopic field with white light and ultraviolet light. Photographs were made
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in color with Super Anscochrome film, daylight type, using 2-4 minute exposures
for fields illuminated with ultraviolet light, and 10-30 second exposures for those
illuminated with white light.
EXPERIMENTAL RESULTS
Effect of streptokinase-activated plasminogen on M protein
In preliminary experiments whole serum was used as a source of
plasminogen; no effect on M protein could be demonstrated. A semi-
quantitative system was devised so that proteolytic activity could be assayed.
TABLE 1. EFFECT OF TRYPSIN ON SKIM MILK AND "M" PROTEIN
SUBSTRATES [24 HOURS AT 370]
Dil. of Trypsin Substrate [0.2 ml.]









Trypsin was selected as an enzyme reference because of its known ability
to destroy M protein.'
Serial dilutions of crystalline trypsin (General Biochemicals, Inc.) were
prepared from a 0.1 per cent solution of 0.01 M phosphate buffer at pH 7.6,
and filtered through a Swinney filter. To 0.8 ml. of trypsin dilution, 0.2
ml. containing 500 gamma of type 1 protein was added. A similar amount
of skimmed milk was added to duplicate trypsin tubes. After incubation at
370 for 24 hours, the tubes containing skimmed milk were read as fol-
lows: 0 - complete clearing; 1+ - slight opalescence; 2+ - moderate
opalescence; 3+ - slight clearing; 4 + - no change from control tube.
After incubation tubes containing M protein were placed in a boiling
water bath for ten minutes to inactivate the trypsin. Capillary precipitin
tests were performed using type-specific antiserum. A maximal precipitin
reaction was recorded as 4+; no reaction was indicated by 0. Results
of this experiment are presented in Table 1.
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Approximately 10 to 100 times the concentration of trypsin needed to
clear skimmed milk was required for hydrolysis of M protein. Under con-
ditions of the experiment this relationship was constant. To determine
whether streptokinase-activated plasminogen was capable of M protein
hydrolysis, concentration of pro-enzyme was necessary so that in dilution
of 10-3, the proteolytic system would clear skimmed milk. Sufficient con-
centration was achieved by starting with 10 grams of Fraction III and
dissolving the lyophilized pro-enzyme in a 4 ml. volume as described
above. Activation of the concentrated plasminogen in the presence of sub-
strate was optimal with five units per milliliter of streptokinase. In sub-
TABLE 2. EFFECT OF STREPTOKINASE-ACTIVATED PLASMINOGEN ON SKIM MILK
AND "M" PROTEIN SUBSTRATES [24 HOURS AT 370 C]
Plasminogen [0.2 ml.] Substrate [0.2 ml.]
Streptokinase [100 U/ml] Dilution Skim Milk "M" Protein
0.6 ml. 100 0 0
0.6 m 10-1 0 0
0.6 " 10-2 0 0
0.6 " 10-3 0 ++ 0.6 " 10-30+ 0.6 "10-4 ++++ ++++
0.6 " 10-5 ++++ ++++
0.6 " Buffer ++++ ++++
Buffer 0.8 ml. None ++++ ++++
sequent experiments streptokinase was always used at ten times the
minimal concentration necessary for optimal activation.
Serial dilutions of plasminogen were prepared in sterile distilled water.
To 0.2 ml. of pro-enzyme, 0.2 ml. of either skimmed milk or M. protein
substrate was added. Streptokinase (100 units/ml.) prepared in 0.01 MI
phosphate buffer at pH 7.6 was pipetted into each tube in 0.6 ml. amounts.
Contact with buffer altered reaction of undiluted plasminogen solutions to
pH 7.6 and precipitation of the pro-enzyme occurred; however, plasminogen
dilutions of 1 :10 or higher appeared stable. After 24 hour incubation at
370 C. tubes containing skimmed milk were read as before; plasmin tubes
were placed in a boiling water bath for ten minutes, cooled, and capillary
precipitin tests performed with type-specific antiserum. The effect of
streptokinase-activated plasminogen on skimmed milk and M protein sub-
strate is illustrated in Table 2. With adequate concentration of pro-enzyme
it was possible to demonstrate hydrolysis of M protein.
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Effect of leukocytes on M protein
To determine the effect of fresh human leukocytes on M protein a
similar system was used. Leukocytes were obtained from peripheral blood
by concentrating the supernate after erythrocyte sedimentation. Cells were
counted, and serial tenfold dilutions made in Tyrode's gelatin buffer; 0.8
ml. of the suspension was added to 0.2 ml. of skimmed milk or M protein
substrate. Incubation at 370 C. proceeded for 24 hours. Although the
suspended white cells initially contributed to the opalescence of the
skimmed milk preparations, sedimentation of leukocytes had occurred at
TABLE 3. EFFECT OF HUMAN LEUKOCYTES ON SKIM MILK AND "M" PROTEIN
SUBSTRATES
Substrate [0.2 ml.]






100 [Heated] ++++ ++++
*WBC =40,000/mm2
24 hours and clearing of the skimmed milk could easily be read. At the
end of the incubation period tubes containing M protein were frozen and
thawed to effect cellular disruption. The debris was removed by centri-
fugation at 15,000 g for 20 minutes and the supernate tested by the
capillary precipitin technique for the presence of M substance. The results
of this experiment are reported in Table 3. Fresh leukocyte suspensions
completely destroyed reactivity of M protein with type-specific antiserum.
Although some loss of M substance was apparent at 1:10 dilution of
leukocytes, complete hydrolysis required 32 x 106 cells. Disruption of
leukocytes following the incubation period was included to detect intra-
cellular M protein.
Fate of M protein after phagocytosis of qriable streptococci
Type 1 and type 12 streptococci were grown overnight in Todd-Hewitt
broth and washed three times in Gey's-albumin solution. Hyaluronidase
(Worthington) was added to concentration of 1 TRU/ml., and the sus-
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Volume 36, February, 1964FIG. 1. Intracellular streptococci immediately after phagocytosis viewed with white
light using the dark field condenser (x970). Note granules as well as cocci are
refractile.
FIG. 2. Same field as above illuminated with ultraviolet light.FIG. 3. Intracellular streptococci 10 minutes after phagocytosis viewed with white
light (x970).
FIG. 4. Same field as above illuminated with ultraviolet light.FIG. 5. Intracellular streptococci 65 miniutes after phagocytosis viewed with white
light (x970).
FIG. 6. Same field as above illuminated with ultraviolet light. Note absence of
bacteria fluorescence.Effect of plasmin and leukocytes on M protein KANTOR
pension incubated 15 minutes at 370 C. A dilution of the suspension equal
to 1:10 of the overnight culture was made in Gey's-albumin solution con-
taining 2 per cent guinea pig complement. Freshly prepared and washed
leukocyte "buttons" were flooded with the bacterial suspension and then
incubated from 5-7 minutes at 370 C. Slides were washed in four changes
of Gey's-albumin buffer to remove extracellular streptococci, then flooded
with fresh buffer and incubated at 370 C. in a moist Petri dish. Prepara-
tions were fixed by rapid drying in an air jet at 5-minute intervals for the
first half hour and every 15 minutes thereafter for 4 hours. Duplicate
slides were stained with Wright's stain and with type-specific fluorescein
conjugated gamma globulin. Although exposure of phagocytes to bacteria
was short, intracellular streptococci were common, many with surrounding
vacuoles. Slides fixed immediately after removal of the bacterial suspension
showed only occasional extracellular streptococci.
Preparations were viewed under oil immersion with white light using
the dark field condenser (Fig. 1). Intracellular streptococci appeared
highly refractile; other cellular particles such as granules, although
moderately refractile, were easily differentiated from cocci. The same field
was then illuminated with ultraviolet light. In those slides fixed immediately
after phagocytosis, streptococci fluoresced a bright greenish-yellow color;
the rest of the cell remained a dark blue (Fig. 2). After intracellular
residence of ten minutes, bright fluorescence of intracellular streptococci
was still apparent (Figures 3 and 4). Slides fixed after 15-75 minutes
of incubation showed progressive irregular loss of fluorescence. At 65
minutes intracellular streptococci were clearly seen in fields illuminated
with white light (Fig. 5). However, loss of M antigen was demonstrated
by absence of fluorescence (Fig. 6). The cytoplasm and nucleus of these
cells also were devoid of antigen. Occasional extracellular chains of
streptococci which eluded initial phagocytosis continued to stain with
specific fluorescein conjugate.
DISCUSSION
Exposure of partially purified streptococcal M protein to streptokinase-
activated plasminogen or to human leukocytes resulted in rapid loss of
reactivity with specific antibody. M antigen, in situ, on the bacterial cell
wall, failed to stain with specific fluorescent conjugate after a short intra-
cellular residence in the polymorphonuclear leukocyte.
These data are wholly consistent with the well-known ability of tryptic-
like enzymes to destroy M protein.' Such proteases are associated with
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cytoplasmic granules with polymorphonuclear leukocytes," and it seems
likely that rapid proteolysis of M protein occurs soon after phagocytic
ingestion. The possibility exists, however, that following phagocytosis,
M antigen is removed intact from the bacterial cell wall and diffuses
throughout the cytoplasm of the phagocyte; reaction with specific
fluorescent conjugate would not be apparent because of antigen dilution.
This explanation seems less tenable since serial slides done at 5-minute
intervals did not reveal diffusion of antigen away from bacteria. Further-
more M protein in serologically reactive form could never be recovered
from disrupted leukocytes following exposure of partially purified M
protein to leukocyte suspensions.
The progressive loss of M-antibody-staining material on the ingested
bacteria was determined by serial preparations which led to an estimate
of intracellular residence necessary to abolish the staining reaction. The
time of disappearance of the M antigen, between 15 and 75 minutes, is
consistent with the bactericidal effects of the leukocyte as measured by
Wilson and Wiley."3 In their studies, intracellular residence of about 8
minutes resulted in loss of viability of 50 per cent of streptococcal chains
following disruption of the leukocyte by means of an electric current. The
time lag from ingestion until destruction of M protein and bacterial death
may be related to the kinetics of the enzyme-substrate systems involved.
An alternate explanation for the lag period in M destruction may involve
processes necessary for the enzyme-bearing granules to contact the
phagocytic vacuole and deposit the appropriate proteases. Visualization of
the phagocytic vacuole was not possible in these studies using dark field
microscopy.
The mechanism of M-antibody production is unknown; however, three
possibilities remain consistent with the data herein presented: 1) The
M antigen, either as a separate extracellular product, or intact on the
bacterium, is carried via lymph channels directly to regional lymphoid tissue
and antibody production is initiated without prior passage of antigen
through phagocytic cells. 2) Another cell such as a macrophage provides
more favorable, i.e. less proteolytic, environment and is thereby suitable
to transport the intact antigen to the antibody-producing apparatus or
3) shortly after ingestion by a phagocytic leukocyte, antigenic information
is conveyed to the phagocyte so that the intact antigen is not required
at the antibody-producing site. Some support for the third alternative is
found in the studies of Fishman' demonstrating the necessity of prior in-
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cubation of bacteriophage with macrophages before a primary antibody
response could be obtained in lymph node cell cultures.
The technique described in the present report allows study of the fate
of various antigens within diverse cell types of the same and different
species.
SUMMARY
Partially purified type 1 streptococcal M protein was destroyed by
exposure to streptokinase-activated plasminogen or to viable human
leukocyte suspensions. After phagocytosis of intact streptococci by human
polymorphonuclear leukocytes and a short intracellular residence, the
bacteria fail to stain with specific fluorescent anti-M conjugates.
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